ApoB/ApoA-I ratio

There are 8 papers on ApoB/ApoA-I ratio in aging research: 1 trial and 6 observational studies in people, 1 review.

Biomarker

8 papers study it1 more mentions it13 findings

4 new papers in 30 daysSee all 9 papers on ApoB/ApoA-I ratio

“The ApoB/ApoA-I ratio was the strongest independent lipid predictor of CHD (adjusted OR 4.49, 95% CI 1.98-10.19).”
The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularizationClinical and experimental hypertension (New York, N.Y. : 1993)2025doi:10.1080/10641963.2025.2603463
  • Human trial1
  • Humans6

Interventions

1

Cold-water swimming

downin humans1

1 study
  1. Cold-water swimming decreases ApoB/ApoA-I ratio in humans (cold water swimmers).

    “The ApoB/ApoA-I ratio in female CWS decreased over the season (P = 0.02)”

    Human trialcold water swimmersbloodover the seasonfemales

    Gender-related effect of cold water swimming on the seasonal changes in lipid profile, ApoB/ApoA-I ratio, and homocysteine concentration in cold water swimmers

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

More on Cold-water swimming

Effects

1

Clinical model discrimination

no changein humans1

1 study
  1. ApoB/ApoA-I ratio was not clearly linked with clinical model discrimination in humans (Added to the base clinical model in maintenance hemodialysis patients).

    “and did not improve discrimination beyond the base clinical model.”

    HumansAdded to the base clinical model in maintenance hemodialysis patientsn = 409

    ApoB/ApoA-I ratio and all-cause mortality in maintenance hemodialysis: a cohort study

    BMC nephrology

Associations

10

LDL-C

mixedin humans1upin humans1

1 study
  1. LDL-C predicts ApoB/ApoA-I ratio in humans (multivariate regression in adults with normal lipid profiles).

    “Multivariate regression identified LDL-C and LDL/ApoB ratio as independent predictors of the ApoB/ApoA-I ratio.”

    Humansmultivariate regression in adults with normal lipid profilesserumn = 104

    ApoB/ApoA-I Ratio Identifies Hidden Atherogenic Risk Beyond Conventional Lipid Parameters in Normolipidemic Adults

    Lipids

  2. ApoB/ApoA-I ratio is associated with LDL-C in humans (normal lipid profiles; ApoB/ApoA-I ratio > 0.8).

    “Participants with an ApoB/ApoA-I ratio > 0.8 showed significantly higher total cholesterol, low-density lipoprotein cholesterol (LDL-C), non-HDL-C, triglycerides, and atherogenic indices”

    Humansnormal lipid profiles; ApoB/ApoA-I ratio > 0.8serumn = 104

    ApoB/ApoA-I Ratio Identifies Hidden Atherogenic Risk Beyond Conventional Lipid Parameters in Normolipidemic Adults

    Lipids

More on LDL-C

LDL/ApoB ratio

mixedin humans1

1 study
  1. LDL/ApoB ratio predicts ApoB/ApoA-I ratio in humans (multivariate regression in adults with normal lipid profiles).

    “Multivariate regression identified LDL-C and LDL/ApoB ratio as independent predictors of the ApoB/ApoA-I ratio.”

    Humansmultivariate regression in adults with normal lipid profilesserumn = 104

    ApoB/ApoA-I Ratio Identifies Hidden Atherogenic Risk Beyond Conventional Lipid Parameters in Normolipidemic Adults

    Lipids

More on LDL/ApoB ratio

Male sex

upin humans1

1 study
  1. Male sex is associated with ApoB/ApoA-I ratio in humans (apparently healthy adults with normal lipid profiles; males compared with females).

    “Males demonstrated significantly higher triglycerides, lower high-density lipoprotein cholesterol (HDL-C) and elevated ApoB/ApoA-I ratios compared with females (p < 0.05).”

    Humansapparently healthy adults with normal lipid profiles; males compared with femalesserumn = 104

    ApoB/ApoA-I Ratio Identifies Hidden Atherogenic Risk Beyond Conventional Lipid Parameters in Normolipidemic Adults

    Lipids

Cardiovascular mortality

no changein humans1

1 study
  1. ApoB/ApoA-I ratio is associated with cardiovascular mortality in humans (Maintenance hemodialysis patients; exploratory Fine-Gray regression) (SHR 1.12, 95% CI 0.89–1.43; p = 0.337).

    “ApoB/ApoA-I was not significantly associated with cardiovascular mortality in exploratory Fine-Gray regression”

    HumansMaintenance hemodialysis patients; exploratory Fine-Gray regressionMedian follow-up of 55.7 monthsn = 409

    ApoB/ApoA-I ratio and all-cause mortality in maintenance hemodialysis: a cohort study

    BMC nephrology

Mortality

upin humans1HR 1.23

1 study
  1. ApoB/ApoA-I ratio is associated with mortality in humans (Maintenance hemodialysis patients; adjusted Model 3; standardized continuous marker) (HR 1.23, 95% CI 1.05–1.44; p = 0.012).

    “but was independently associated with all-cause mortality in Model 3 (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.05-1.44; p = 0.012).”

    HumansMaintenance hemodialysis patients; adjusted Model 3; standardized continuous markerMedian follow-up of 55.7 monthsn = 409

    ApoB/ApoA-I ratio and all-cause mortality in maintenance hemodialysis: a cohort study

    BMC nephrology

Coronary artery disease and clinical endpoints

upin humans1

1 study
  1. ApoB/ApoA-I ratio predicts coronary artery disease and clinical endpoints in humans (ROC curve analysis) (AUCs 0.569-0.608).

    “The ratio showed significant discriminatory power for all endpoints (AUCs 0.569-0.608).”

    HumansROC curve analysisn = 7,277

    The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization

    Clinical and experimental hypertension (New York, N.Y. : 1993)

More on Coronary artery disease and clinical endpoints

Percutaneous coronary intervention requirement

upin humans1OR 1.95

1 study
  1. ApoB/ApoA-I ratio is associated with percutaneous coronary intervention requirement in humans after multivariable logistic regression (OR 1.95, 95% CI 1.43-2.66).

    “It significantly predicted severe clinical phenotypes: AMI (OR 1.94, 95% CI 1.44-2.62), MVD (OR 1.67, 95% CI 1.24-2.26), and PCI requirement (OR 1.95, 95% CI 1.43-2.66).”

    Humansafter multivariable logistic regressionn = 7,277

    The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization

    Clinical and experimental hypertension (New York, N.Y. : 1993)

Multivessel disease

upin humans1OR 1.67

1 study
  1. ApoB/ApoA-I ratio is associated with multivessel disease in humans after multivariable logistic regression (OR 1.67, 95% CI 1.24-2.26).

    “It significantly predicted severe clinical phenotypes: AMI (OR 1.94, 95% CI 1.44-2.62), MVD (OR 1.67, 95% CI 1.24-2.26), and PCI requirement (OR 1.95, 95% CI 1.43-2.66).”

    Humansafter multivariable logistic regressionn = 7,277

    The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization

    Clinical and experimental hypertension (New York, N.Y. : 1993)

More on Multivessel disease

Acute myocardial infarction

upin humans1OR 1.94

1 study
  1. ApoB/ApoA-I ratio is associated with acute myocardial infarction in humans after multivariable logistic regression (OR 1.94, 95% CI 1.44-2.62).

    “It significantly predicted severe clinical phenotypes: AMI (OR 1.94, 95% CI 1.44-2.62)”

    Humansafter multivariable logistic regressionn = 7,277

    The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization

    Clinical and experimental hypertension (New York, N.Y. : 1993)

More on Acute myocardial infarction

Coronary artery disease

upin humans1OR 4.49

1 study
  1. ApoB/ApoA-I ratio is associated with coronary artery disease in humans after multivariable logistic regression (adjusted OR 4.49, 95% CI 1.98-10.19).

    “The ApoB/ApoA-I ratio was the strongest independent lipid predictor of CHD (adjusted OR 4.49, 95% CI 1.98-10.19).”

    Humansafter multivariable logistic regressionn = 7,277

    The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization

    Clinical and experimental hypertension (New York, N.Y. : 1993)

More on Coronary artery disease

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 2Nov 2026: 16 papers in 12 months